Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant

Author:

Khan KhadijaORCID,Lustig Gila,Römer CorneliusORCID,Reedoy Kajal,Jule Zesuliwe,Karim Farina,Ganga Yashica,Bernstein MalloryORCID,Baig Zainab,Jackson Laurelle,Mahlangu Boitshoko,Mnguni AneleORCID,Nzimande Ayanda,Stock Nadine,Kekana Dikeledi,Ntozini Buhle,van Deventer Cindy,Marshall Terry,Manickchund Nithendra,Gosnell Bernadett I.ORCID,Lessells Richard J.ORCID,Karim Quarraisha AbdoolORCID,Abdool Karim Salim S.ORCID,Moosa Mahomed-Yunus S.ORCID,de Oliveira TulioORCID,von Gottberg AnneORCID,Wolter NicoleORCID,Neher Richard A.ORCID,Sigal AlexORCID

Abstract

AbstractOmicron BA.2.86 subvariant differs from Omicron BA.2 as well as recently circulating variants by over 30 mutations in the spike protein alone. Here we report on the isolation of the live BA.2.86 subvariant from a diagnostic swab collected in South Africa which we tested for escape from neutralizing antibodies and viral replication properties in cell culture. We found that BA.2.86 does not have significantly more escape relative to Omicron XBB.1.5 from neutralizing immunity elicited by either Omicron XBB-family subvariant infection or from residual neutralizing immunity of recently collected sera from the South African population. BA.2.86 does have extensive escape relative to ancestral virus with the D614G substitution (B.1 lineage) when neutralized by sera from pre-Omicron vaccinated individuals and relative to Omicron BA.1 when neutralized by sera from Omicron BA.1 infected individuals. BA.2.86 and XBB.1.5 show similar viral infection dynamics in the VeroE6-TMPRSS2 and H1299-ACE2 cell lines. We also investigate the relationship of BA.2.86 to BA.2 sequences. The closest BA.2 sequences are BA.2 samples from Southern Africa circulating in early 2022. Similarly, many basal BA.2.86 sequences were sampled in Southern Africa. This suggests that BA.2.86 potentially evolved in this region, and that unobserved evolution led to escape from neutralizing antibodies similar in scale to recently circulating strains of SARS-CoV-2.

Funder

Bill and Melinda Gates Foundation

Wellcome Trust

South African Medical Research Council

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3